Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early therapy of pulmonary arterial hypertension (PAH) with Bosentan in connective tissue disease
2007-004288-23Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Medical University of Graz. Started Mar 2008; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2007-004288-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004288-23.